Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Prevention of Poor Hematopoietic Reconstitution in Haplo-HSCT
NCT03967665Phase 3Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Oct 2018
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine, sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
acetylcysteine
Beyond the preview
Go deeper on NCT03967665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03967665.